
NAMPT
Marisela breaks down NAMPT, the rate-limiting enzyme to NAD production, and how it transforms into an inflammatory biomarker when secreted from the cell.
Arizona Tech Week 2026
Longevity Director · uGenome
I spent years mapping the molecular switch that steals your energy. Now I'm translating that science into tools that help everyone live longer and live well.

Origin
I went to the University of Arizona as a biochemistry major, convinced that medical school was my path. Our program strongly encouraged undergrads to get hands-on lab exposure alongside their coursework; it was a rigorous degree and research was meant to bring it to life. So I started messaging professors right away. Nobody wrote back.
It was through a summer program that I finally landed in the laboratory of Dr. Jason Yuan. I had never been exposed to research before, and something clicked. I started to fall in love with it in a way I hadn't anticipated. So when that summer session ended, I walked directly to Dr. Yuan and asked if I could stay, as an undergraduate, continuing to learn. He said yes. That yes gave me my first real break into research.
That experience set the entire trajectory that followed. The lab became the place where I discovered what I was actually chasing: not a degree, not a title, but a deep understanding of the molecular machinery that keeps us alive.

First Break
Marisela on the summer program that landed her in Dr. Jason Yuan's lab and the moment she fell in love with research.
Present
My PhD research focused on the rate-limiting enzyme in NAD production: NAMPT, nicotinamide phosphoribosyltransferase. NAD is the foundational energy molecule that fuels every metabolic reaction in your body. It is evolutionarily conserved, present in all organisms in the animal kingdom. When your NAD pathways function well, your cells produce energy efficiently. When they don't, things start to break down.
What I discovered is that when NAMPT is secreted out of the cell, it transforms into an inflammatory biomarker. We have found it at elevated levels in patient blood plasma across almost all chronic diseases we have measured. I went deep into the mechanisms that allow that protein to stop energy production, escape into the bloodstream, and drive tissue damage. Think of it as a seesaw: NAD production on one side, chronic inflammation on the other. The work is about understanding that balance and figuring out how to shift it.
That research led me to the longevity space, where I now serve as Longevity Director at uGenome - an AI genomics company. I help translate scientific jargon for people without a research background, making it actionable. I also partner with the Alliance for Longevity Initiatives and Longevity Global, which is now establishing chapters worldwide and bringing together investors, scientists, academics, and community members who care about what it means to live not just longer, but well.

What Is NAD?
Marisela explains why NAD is the foundational energy molecule and what happens when your body stops making enough of it.
Future
Not one magic molecule, many things working in concert.
I recently completed my PhD and made the deliberate choice not to pursue a postdoc or a professorship. I am stepping into the unknown, building my network, exploring what is possible, and learning everything I can about how science and technology are converging right now. Arizona Tech Week has been a window into that convergence: AI and art creating new forms of storytelling, AI safety and transparency becoming urgent infrastructure questions, the entire field moving faster than any one lab can keep up with.
The bigger question I am sitting with is this: we know so much about how NAMPT drives inflammation and drains our energy reserves across chronic disease, but can we design interventions that shift the whole pathway? Better air, better food, smarter supplementation, targeted therapies. Not one small molecule to make all the difference, but many things working together. That is the research frontier I want to be part of building.
Fast Facts
Company
uGenome
Role
Longevity Director
Education
PhD, University of Arizona (Biochemistry)
Research
NAMPT / NAD production pathways; chronic disease inflammation
Organizations
Alliance for Longevity Initiatives · Longevity Global
Event
Arizona Tech Week 2026
Watch More

Marisela breaks down NAMPT, the rate-limiting enzyme to NAD production, and how it transforms into an inflammatory biomarker when secreted from the cell.

Marisela on her work in the longevity space: the Alliance for Longevity Initiatives, Longevity Global, and her role translating science for non-specialist audiences.

The conversation turns to personalized health AI, a Baymax or Jarvis for your own DNA and health records.

Marisela goes deeper on the NAMPT pathway: the seesaw between NAD production and chronic inflammation, and how to think about shifting it.
“I visualize it as a seesaw on the playground; it's that very delicate balance.”
Follow Marisela Rodriguez, PhD's work or reach out through the links below.
Related profiles from Arizona Tech Week 2026

Scientific & Business Development Director · uGenome
Genomics generates the data. The real challenge is interpreting it, and we built the software that makes sense of every variant, every pathway, every person.
View Profile →
Founder · uGenome
I'm building the tools that make your DNA your most powerful health asset, making genomic medicine personal and accessible for everyone.
View Profile →
CFO & Co-Founder · Clinix AI
I learned finance sitting with a CFO after hours. Now I'm the one signing off on every dollar, and we're building the tool that gives medicine back its soul.
View Profile →
CEO, Exponent Labs | Engineering Manager, Elysium Health · Exponent Labs
From MySpace themes in middle school to engineering AI agents at a longevity company. I build, mentor, and show up wherever the future is being made.
View Profile →